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AbstrACt
background Several scales, checklists and domain-
based tools for assessing risk of reporting biases exist, but 
it is unclear how much they vary in content and guidance. 
We conducted a systematic review of the content and 
measurement properties of such tools.
Methods We searched for potentially relevant articles in 
Ovid MEDLINE, Ovid Embase, Ovid PsycINFO and Google 
Scholar from inception to February 2017. One author 
screened all titles, abstracts and full text articles, and 
collected data on tool characteristics.
results We identified 18 tools that include an assessment 
of the risk of reporting bias. Tools varied in regard to the 
type of reporting bias assessed (eg, bias due to selective 
publication, bias due to selective non-reporting), and 
the level of assessment (eg, for the study as a whole, a 
particular result within a study or a particular synthesis of 
studies). Various criteria are used across tools to designate 
a synthesis as being at ‘high’ risk of bias due to selective 
publication (eg, evidence of funnel plot asymmetry, use 
of non-comprehensive searches). However, the relative 
weight assigned to each criterion in the overall judgement 
is unclear for most of these tools. Tools for assessing 
risk of bias due to selective non-reporting guide users to 
assess a study, or an outcome within a study, as ‘high’ risk 
of bias if no results are reported for an outcome. However, 
assessing the corresponding risk of bias in a synthesis that 
is missing the non-reported outcomes is outside the scope 
of most of these tools. Inter-rater agreement estimates 
were available for five tools.
Conclusion There are several limitations of existing tools 
for assessing risk of reporting biases, in terms of their 
scope, guidance for reaching risk of bias judgements and 
measurement properties. Development and evaluation of 
a new, comprehensive tool could help overcome present 
limitations.
bACkground 
The credibility of evidence syntheses can be 
compromised by reporting biases, which arise 
when dissemination of research findings is 
influenced by the nature of the results.1 For 
example, there may be bias due to selective 
publication, where a study is only published if 
the findings are considered interesting (also 
known as publication bias).2 In addition, bias 
due to selective non-reporting may occur, 
where findings (eg, estimates of intervention 
efficacy or an association between exposure 
and outcome) that are statistically non-signifi-
cant are not reported or are partially reported 
in a paper (eg, stating only that ‘P>0.05’).3 
Alternatively, there may be bias in selection of 
the reported result, where authors perform 
multiple analyses for a particular outcome/
association, yet only report the result which 
yielded the most favourable effect estimate.4 
Evidence from cohorts of clinical trials 
followed from inception suggest that biased 
dissemination is common. Specifically, on 
average, half of all trials are not published,1 5 
trials with statistically significant results are 
twice as likely to be published5 and a third 
of trials have outcomes that are omitted, 
added or modified between protocol and 
publication.6 
Audits of systematic review conduct suggest 
that most systematic reviewers do not assess 
risk of reporting biases.7–10 For example, in a 
cross-sectional study of 300 systematic reviews 
indexed in MEDLINE in February 2014,7 the 
risk of bias due to selective publication was not 
strengths and limitations of this study
 ► Tools for assessing risk of reporting biases, and 
studies evaluating their measurement properties, 
were identified by searching several relevant 
databases using a search string developed in 
conjunction with an information specialist.
 ► Detailed information on the content and measurement 
properties of existing tools was collected, providing 
readers with pertinent information to help decide 
which tools to use in evidence syntheses.
 ► Screening of articles and data collection were 
performed by one author only, so it is possible that 
some relevant articles were missed, or that errors in 
data collection were made.
 ► The search of grey literature was not comprehensive, 
so it is possible that there are other tools for 
assessing risk of reporting biases, and unpublished 
studies evaluating measurement properties, that 
were omitted from this review.
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considered in 56% of reviews. A common reason for not 
doing so was that the small number of included studies, or 
inability to perform a meta-analysis, precluded the use of 
funnel plots. Only 19% of reviews included a search of a 
trial registry to identify completed but unpublished trials 
or prespecified but non-reported outcomes, and only 7% 
included a search of another source of data disseminated 
outside of journal articles. The risk of bias due to selective 
non-reporting in the included studies was assessed in only 
24% of reviews.7 Another study showed that authors of 
Cochrane reviews routinely record whether any outcomes 
that were measured were not reported in the included 
trials, yet rarely consider if such non-reporting could have 
biased the results of a synthesis.11
Previous researchers have summarised the characteris-
tics of tools designed to assess various sources of bias in 
randomised trials,12–14 non-randomised studies of inter-
ventions (NRSI),14 15 diagnostic test accuracy studies16 
and systematic reviews.14 17 Others have summarised the 
performance of statistical methods developed to detect 
or adjust for reporting biases.18–20 However, no prior 
review has focused specifically on tools (ie, structured 
instruments such as scales, checklists or domain-based 
tools) for assessing the risk of reporting biases. A partic-
ular challenge when assessing risk of reporting biases is 
that existing tools vary in their level of assessment. For 
example, tools for assessing risk of bias due to selective 
publication direct assessments at the level of the synthesis, 
whereas tools for assessing risk of bias due to selective 
non-reporting within studies can direct assessments at the 
level of the individual study, at the level of the synthesis or 
at both levels. It is unclear how many tools are available to 
assess different types of reporting bias, and what level they 
direct assessments at. It is also unclear whether criteria 
for reaching risk of bias judgements are consistent across 
existing tools. Therefore, the aim of this research was to 
conduct a systematic review of the content and measure-
ment properties of such tools.
Methods
Protocol
Methods for this systematic review were prespecified in a 
protocol which was uploaded to the Open Science Frame-
work in February 2017 (https:// osf. io/ 9ea22/).
eligibility criteria
Papers were included if the authors described a tool that 
was designed for use by individuals performing evidence 
syntheses to assess risk of reporting biases in the included 
studies or in their synthesis of studies. Tools could assess 
any type of reporting bias, including bias due to selective 
publication, bias due to selective non-reporting or bias in 
selection of the reported result. Tools could assess the risk 
of reporting biases in any type of study (eg, randomised 
trial of intervention, diagnostic test accuracy study, obser-
vational study estimating prevalence of an exposure) and 
in any type of result (eg, estimate of intervention efficacy 
or harm, estimate of diagnostic accuracy, association 
between exposure and outcome). Eligible tools could 
take any form, including scales, checklists and domain-
based tools. To be considered a scale, each item had to 
have a numeric score attached to it, so that an overall 
summary score could be calculated.12 To be considered a 
checklist, the tool had to include multiple questions, but 
the developers’ intention was not to attach a numerical 
score to each response, or to calculate an overall score.13 
Domain-based tools were those that required users to 
judge risk of bias or quality within specific domains, and 
to record the information on which each judgement was 
based.21
Tools with a broad scope, for example, to assess 
multiple sources of bias or the overall quality of the body 
of evidence, were eligible if one of the items covered risk 
of reporting bias. Multidimensional tools with a statistical 
component were also eligible (eg, those that require users 
to respond to a set of questions about the comprehensive-
ness of the search, as well as to perform statistical tests for 
funnel plot asymmetry). In addition, any studies that eval-
uated the measurement properties of existing tools (eg, 
construct validity, inter-rater agreement, time taken to 
complete assessments) were eligible for inclusion. Papers 
were eligible regardless of the date or format of publica-
tion, but were limited to those written in English.
The following were ineligible:
 ► articles or book chapters providing guidance on how 
to address reporting biases, but which do not include 
a structured tool that can be applied by users (eg, 
the 2011 Cochrane Handbook chapter on reporting 
biases22);
 ► tools developed or modified for use in one particular 
systematic review;
 ► tools designed to appraise published systematic 
reviews, such as the Risk Of Bias In Systematic reviews 
(ROBIS) tool23 or A MeaSurement Tool to Assess 
systematic Reviews (AMSTAR)24;
 ► articles that focus on the development or evaluation 
of statistical methods to detect or adjust for reporting 
biases, as these have been reviewed elsewhere.18–20
search methods
On 9 February 2017, one author (MJP) searched for 
potentially relevant records in Ovid MEDLINE (January 
1946 to February 2017), Ovid Embase (January 1980 to 
February 2017) and Ovid PsycINFO (January 1806 to 
February 2017). The search strategies included terms 
relating to reporting bias which were combined with a 
search string used previously by Whiting et al to identify 
risk of bias/quality assessment tools17 (see full Boolean 
search strategies in online supplementary table S1).
To capture any tools not published by formal academic 
publishers, we searched Google Scholar using the phrase 
‘reporting bias tool OR risk of bias’. One author (MJP) 
screened the titles of the first 300 records, as recom-
mended by Haddaway et al.25 To capture any papers that 
may have been missed by all searches, one author (MJP) 
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screened the references of included articles. In April 
2017, the same author emailed the list of included tools 
to 15 individuals with expertise in reporting biases and 
risk of bias assessment, and asked if they were aware of 
any other tools we had not identified.
study selection and data collection
One author (MJP) screened all titles and abstracts 
retrieved by the searches. The same author screened any 
full-text articles retrieved. One author (MJP) collected 
data from included papers using a standardised data-col-
lection form. The following data on included tools were 
collected:
 ► type of tool (scale, checklist or domain-based tool);
 ► types of reporting bias addressed by the tool;
 ► level of assessment (ie, whether users direct assess-
ments at the synthesis or at the individual studies 
included in the synthesis);
 ► whether the tool is designed for general use (generic) 
or targets specific study designs or topic areas 
(specific);
 ► items included in the tool;
 ► how items within the tool are rated;
 ► methods used to develop the tool (eg, Delphi study, 
expert consensus meeting);
 ► availability of guidance to assist with completion of 
the tool (eg, guidance manual).
The following data from studies evaluating measure-
ment properties of an included tool were collected:
 ► tool evaluated
 ► measurement properties evaluated (eg, inter-rater 
agreement)
 ► number of syntheses/studies evaluated
 ► publication year of syntheses/studies evaluated
 ► areas of healthcare addressed by syntheses/studies 
evaluated
 ► number of assessors
 ► estimate (and precision) of psychometric statistics 
(eg, weighted kappa; κ).
data analysis
We summarised the characteristics of included tools in 
tables. We calculated the median (IQR) number of items 
across all tools, and tabulated the frequency of different 
criteria used in tools to denote a judgement of ‘high’ risk 
of reporting bias. We summarised estimates of psycho-
metric statistics, such as weighted κ to estimate inter-
rater agreement,26 by reporting the range of values across 
studies. For studies reporting weighted κ, we categorised 
agreement according to the system proposed by Landis 
and Koch,27 as poor (0.00), slight (0.01–0.20), fair (0.21–
0.40), moderate (0.41–0.60), substantial (0.61–0.80) or 
almost perfect (0.81–1.00).
results
In total, 5554 records were identified from the searches, of 
which we retrieved 165 for full-text screening (figure 1). 
The inclusion criteria were met by 42 reports summarising 
18 tools (table 1) and 17 studies evaluating the measure-
ment properties of tools.3 4 21 28–66 A list of excluded papers 
is presented in online supplementary table S2. No addi-
tional tools were identified by the 15 experts contacted.
general characteristics of included tools
Nearly all of the included tools (16/18; 89%) were 
domain-based, where users judge risk of bias or quality 
within specific domains (table 2; individual characteris-
tics of each tool are presented in online supplementary 
table S3). All tools were designed for generic rather 
than specific use. Five tools focused solely on the risk 
of reporting biases3 28 29 47 48; the remainder addressed 
reporting biases and other sources of bias/methodolog-
ical quality (eg, problems with randomisation, lack of 
blinding). Half of the tools (9/18; 50%) addressed only 
one type of reporting bias (eg, bias due to selective non-re-
porting only). Tools varied in regard to the study design 
that they assessed (ie, randomised trial, non-randomised 
study of an intervention, laboratory animal experiment). 
The publication year of the tools ranged from 1998 to 
2016 (the earliest was the Downs-Black tool,31 a 27-item 
tool assessing multiple sources of bias, one of which 
focuses on risk of bias in the selection of the reported 
result).
Assessments for half of the tools (9/18; 50%) are 
directed at an individual study (eg, tool is used to assess 
whether any outcomes in a study were not reported). In 
5/18 (28%) tools, assessments are directed at a specific 
outcome or result within a study (eg, tool is used to assess 
whether a particular outcome in a study, such as pain, was 
not reported). In a few tools (4/18; 22%), assessments 
are directed at a specific synthesis (eg, tool is used to 
assess whether a particular synthesis, such as a meta-anal-
ysis of studies examining pain as an outcome, is missing 
unpublished studies).
The content of the included tools was informed by 
various sources of data. The most common included a 
literature review of items used in existing tools or a liter-
ature review of empirical evidence of bias (9/18; 50%), 
ideas generated at an expert consensus meeting (8/18; 
44%) and pilot feedback on a preliminary version of 
the tool (7/18; 39%). The most common type of guid-
ance available for the tools was a brief annotation per 
item/response option (9/18; 50%). A detailed guidance 
manual is available for four (22%) tools.
tool content
Four tools include items for assessing risk of bias due 
to both selective publication and selective non-re-
porting.29 33 45 49 One of these tools (the AHRQ tool for 
evaluating the risk of reporting bias29) directs users to 
assess a particular synthesis, where a single risk of bias 
judgement is made based on information about unpub-
lished studies and under-reported outcomes. In the other 
three tools (the GRADE framework, and two others which 
are based on GRADE),33 45 49 the different sources of 
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reporting bias are assessed in separate domains (bias due 
to selective non-reporting is considered in a ‘study limita-
tions (risk of bias)’ domain, while bias due to selective 
publication is considered in a ‘publication bias’ domain).
Five tools21 28 43 44 47 guide users to assess risk of bias 
due to both selective non-reporting and selection of the 
reported result (ie, problems with outcomes/results that 
are not reported and those that are reported, respectively). 
Four of these tools, which include the Cochrane risk of 
bias tool for randomised trials21 and three others which 
are based on the Cochrane tool,43 44 47 direct assessments 
at the study level. That is, a whole study is rated at ‘high’ 
risk of reporting bias if any outcome/result in the study 
has been omitted, or fully reported, on the basis of the 
findings.
Some of the tools designed to assess the risk of bias 
due to selective non-reporting ask users to assess, for 
particular outcomes of interest, whether the outcome 
was not reported or only partially reported in the study 
on the basis of its results (eg, Outcome Reporting 
Bias In Trials (ORBIT) tools,3 48 the AHRQ outcome 
reporting bias framework,28 and GRADE.34 This allows 
Figure 1 Flow diagram of identification, screening and inclusion of studies. aRecords identified from Ovid MEDLINE, Ovid 
Embase, Ovid PsycINFO and Google Scholar. bRecords identified from screening references of included articles. SR, systematic 
review.
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users to perform multiple outcome-level assessments of 
the risk of reporting bias (rather than one assessment 
for the study as a whole). In total, 15 tools include a 
mechanism for assessing risk of bias due to selec-
tive non-reporting in studies, but assessing the corre-
sponding risk of bias in a synthesis that is missing the 
Table 1 List of included tools
Article ID Tool Scope of tool
Types of reporting biases assessed
Level of 
assessment*
Selective 
publication
Selective non-
reporting
Selection of the 
reported result
Balshem et al28 Agency for Healthcare Research 
and Quality (AHRQ) outcome and 
analysis reporting bias framework
Reporting bias only ✓ ✓ Specific 
outcome/result in 
a study
Berkman et al29 AHRQ tool for evaluating the risk 
of reporting bias
Reporting bias only ✓ ✓ Specific 
synthesis of 
studies
Downes et al30 Appraisal tool for Cross-Sectional 
Studies (AXIS) tool
Multiple sources 
of bias
✓ Study
Downs and Black31 Downs-Black tool Multiple sources 
of bias
✓ Study
Guyatt et al33–37 Grading of Recommendations 
Assessment, Development and 
Evaluation (GRADE)
Multiple sources 
of bias
✓ ✓ Specific 
synthesis of 
studies
Hayden et al38 Quality In Prognosis Studies 
(QUIPS) tool
Multiple sources 
of bias
✓ Study
Higgins et al21 39 40 Cochrane risk of bias tool for 
randomised trials (RoB 1.0)
Multiple sources 
of bias
✓ ✓ Study
Higgins et al41 42 RoB 2.0 revised tool for assessing 
risk of bias in randomised trials
Multiple sources 
of bias
✓ Specific 
outcome/result in 
a study
Hoojimans et al43 SYstematic Review Centre 
for Laboratory animal 
Experimentation (SYRCLE) RoB 
tool
Multiple sources 
of bias
✓ ✓ Study
Kim et al44  Risk of Bias Assessment Tool 
for Nonrandomized Studies 
(RoBANS)
Multiple sources 
of bias
✓ ✓ Study
Kirkham et al3 32 Outcome Reporting Bias In Trials I 
(ORBIT-I) classification system for 
benefit outcomes
Reporting bias only ✓ Specific 
outcome/result in 
a study
Meader et al45 46 Semi-Automated Quality 
Assessment Tool (SAQAT)
Multiple sources 
of bias
✓ ✓ Specific 
synthesis of 
studies
Reid et al47 Selective reporting bias algorithm Reporting bias only ✓ ✓ Study
Saini et al48 ORBIT-II classification system for 
harm outcomes
Reporting bias only ✓ Specific 
outcome/result in 
a study
Salanti et al49 50 Framework for evaluating the 
quality of evidence from a network 
meta-analysis
Multiple sources 
of bias
✓ ✓ Specific 
synthesis of 
studies
Sterne et al4 Risk Of Bias In Non-randomized 
Studies of Interventions I 
(ROBINS-I) tool
Multiple sources 
of bias
✓ Specific 
outcome/result in 
a study
Viswanathan and 
Berkman51
Research Triangle Institute 
(RTI) item bank for assessment 
of risk of bias and precision 
for observational studies of 
interventions or exposures
Multiple sources 
of bias
✓ Study
Viswanathan et al52 RTI item bank for assessing 
risk of bias and confounding 
for observational studies of 
interventions or exposures
Multiple sources 
of bias
✓ Study
*Level of assessment classified as: ‘study’ when assessments are directed at a study as a whole (eg, tool used to assess whether any outcomes in a 
study were not reported); ‘specific outcome/result in a study’ when assessments are directed at a specific outcome or result within a study (eg, tools 
used to assess whether a particular outcome, such as pain, was not reported) or ‘specific synthesis of studies’ when assessments are directed at a 
specific synthesis (eg, tool used to assess whether a particular synthesis, such as a meta-analysis of pain, is missing unpublished studies).
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non-reported outcomes is not within the scope of 11 of 
these tools.3 21 28 30 38 43 44 47 48 51 52
A variety of criteria are used in existing tools to inform 
a judgement of ‘high’ risk of bias due to selective publi-
cation (table 3), selective non-reporting (table 4), and 
selection of the reported result (table 5; more detail is 
provided in online supplementary table S4). In the four 
tools with an assessment of risk of bias due to selective 
publication, ‘high’ risk criteria include evidence of funnel 
plot asymmetry, discrepancies between published and 
unpublished studies, use of non-comprehensive searches 
and presence of small, ‘positive’ studies with for-profit 
interest (table 3). However, not all of these criteria appear 
in all tools (only evidence of funnel plot asymmetry does), 
and the relative weight assigned to each criterion in the 
overall risk of reporting bias judgement is clear for only 
one tool (the Semi-Automated Quality Assessment Tool; 
SAQAT).45 46
All 15 tools with an assessment of the risk of bias due 
to selective non-reporting suggest that the risk of bias is 
‘high’ when it is clear that an outcome was measured but 
no results were reported (table 4). Fewer of these tools 
(n=8; 53%) also recommend a ‘high’ risk judgement 
when results for an outcome are partially reported (eg, it 
is stated that the result was non-significant, but no effect 
estimate or summary statistics are presented).
The eight tools that include an assessment of the risk 
of bias in selection of the reported result recommend 
various criteria for a ‘high’ risk judgement (table 5). 
These include when some outcomes that were not 
Table 2 Summary of general characteristics of included 
tools
Characteristic
Summary data 
(n=18 tools)
Type of tool
  Domain-based 16 (89%)
  Checklist 1 (6%)
  Scale 1 (6%)
Scope of tool
  Assessment of reporting bias only 5 (28%)
  Assessment of multiple sources of bias/
quality
13 (72%)
Types of reporting bias assessed
  Bias due to selective publication only 0 (0%)
  Bias due to selective non-reporting only 6 (33%)
  Bias in selection of the reported result 
only
3 (17%)
  Bias due to selective publication and 
bias due to selective non-reporting
4 (22%)
  Bias due to selective non-reporting and 
bias in selection of the reported result
5 (28%)
Total number of items in the tool 7 (5–13)
Number of items relevant to risk of 
reporting bias
1 (1–2)
Number of response options for risk of 
reporting bias judgement
3 (3–3)
Types of study designs to which the tool 
applies
  Randomised trials only 5 (28%)
  Systematic reviews only 3 (17%)
  Non-randomised studies of 
interventions only
2 (11%)
  Randomised trials and non-randomised 
studies of interventions
2 (11%)
  Non-randomised studies of 
interventions or exposures
2 (11%)
  Other (cross-sectional studies, animal 
studies, network meta-analyses, 
prognosis studies)
4 (22%)
Level of assessment of risk of reporting 
bias
  Study as a whole 9 (50%)
  Specific outcome/result in a study 5 (28%)
  Specific synthesis of studies 4 (22%)
Data sources used to inform tool content*
  Literature review (eg, of items in 
existing tools or empirical evidence)
9 (50%)
  Ideas generated at expert consensus 
meeting
8 (44%)
  Pilot feedback on preliminary version of 
the tool
7 (39%)
  Data from psychometric or cognitive 
testing†
5 (28%)
Continued
Characteristic
Summary data 
(n=18 tools)
  Other (eg, adaptation of existing tool) 5 (28%)
  Delphi study responses 2 (11%)
  No methods stated 2 (11%)
Guidance available
  Brief annotation per item/response 
option
9 (50%)
  Detailed guidance manual 4 (22%)
  Worked example for each response 
option
2 (11%)
  Detailed annotation per item/response 
option
1 (6%)
  None 2 (11%)
Summary data given as number (%) or median (IQR).
*The percentages in this category do not sum to 100% since 
the development of some tools was informed by multiple data 
sources.
†Psychometric testing includes any evaluation of the 
measurement properties (eg, construct validity, inter-rater 
reliability, test–retest reliability) of a draft version of the tool. 
Cognitive testing includes use of qualitative methods (eg, 
interview) to explore whether assessors who are using the tool 
for the first time were interpreting the tool and guidance as 
intended.
Table 2 Continued 
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prespecified are added post hoc (in 4 (50%) tools), or 
when it is likely that the reported result for a particular 
outcome has been selected, on the basis of the findings, 
from among multiple outcome measurements or analyses 
within the outcome domain (in 2 (25%) tools).
general characteristics of studies evaluating measurement 
properties of included tools
Despite identifying 17 studies that evaluated measure-
ment properties of an included tool, psychometric statis-
tics for the risk of reporting bias component were available 
only from 12 studies43 44 54–60 62 64 66 (the other five studies 
include only data on properties of the multidimensional 
tool as a whole31 53 61 63 65; online supplementary table 
S5). Nearly all 12 studies (11; 92%) evaluated inter-rater 
agreement between two assessors; eight of these studies 
reported weighted κ values, but only two described the 
weighting scheme.55 62 Eleven studies43 44 54–60 64 66 evalu-
ated the measurement properties of tools for assessing 
risk of bias in a study due to selective non-reporting or 
risk of bias in selection of the reported result; in these 
11 studies, a median of 40 (IQR 32–109) studies were 
assessed. One study62 evaluated a tool for assessing risk of 
bias in a synthesis due to selective publication, in which 
44 syntheses were assessed. In the studies evaluating inter-
rater agreement, all involved two assessors.
results of evaluation studies
Five studies54 56–58 60 included data on the inter-rater 
agreement of assessments of risk of bias due to selec-
tive non-reporting using the Cochrane risk of bias tool 
for randomised trials21 (table 6). Weighted κ values 
in four studies54 56–58 ranged from 0.13 to 0.50 (sample 
size ranged from 87 to 163 studies), suggesting slight to 
moderate agreement.27 In the other study,60 the per cent 
agreement in selective non-reporting assessments in trials 
that were included in two different Cochrane reviews was 
low (43% of judgements were in agreement). Two other 
studies found that inter-rater agreement of selective 
non-reporting assessments were substantial for SYRCLE’s 
RoB tool (κ=0.62, n=32),43 but poor for the RoBANS tool 
(κ=0, n=39).44 There was substantial agreement between 
Table 3 Criteria used in existing tools to inform a judgement of ‘high’ risk of bias due to selective publication
‘High’ risk of bias criteria proposed in existing tools
AHRQ 
RRB GRADE SAQAT NMA-Quality Total, n (%)
Assessment directed at a specific synthesis (eg, meta-
analysis)
  Evidence of funnel plot asymmetry (based on visual 
inspection of funnel plot or statistical test for funnel plot 
asymmetry)
✓ ✓ ✓ ✓ 4 (100)
  Smaller studies tend to demonstrate more favourable 
results (based on visual assessment, without funnel plot)
✓ 1 (25)
  Clinical decision would differ for estimates from a fixed-
effect versus a random-effects model because the findings 
from a fixed-effect model are closer to the null
✓ 1 (25)
  Substantial heterogeneity in the meta-analysis cannot be 
explained by some clinical or methodological factor
✓ 1 (25)
  At least one study is affected by non-publication or non-
accessibility
✓ 1 (25)
  Presence of small (often ‘positive’) studies with for-profit 
interest in the synthesis
✓ ✓ 2 (50)
  Presence of early studies (ie, set of small, ‘positive’ trials 
addressing a novel therapy) in the synthesis
✓ ✓ 2 (50)
  Discrepancy in findings between published and 
unpublished trials
✓ ✓ ✓ 3 (75)
  Search strategies were not comprehensive ✓ ✓ ✓ 3 (75)
  Methods to identify all available evidence were not 
comprehensive
✓ ✓ 2 (50)
  Grey literature were not searched ✓ 1 (25)
  Restrictions to study selection on the basis of language 
were applied
✓ 1 (25)
  Industry influence may apply to studies included in the 
synthesis
✓ 1 (25)
AHRQ RRB, AHRQ tool for evaluating the risk of reporting bias29; GRADE, GRADE rating of quality of evidence34–37; NMA-Quality, Framework 
for evaluating the quality of evidence from a network meta-analysis49; SAQAT, Semi-Automated Quality Assessment Tool.45 46
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raters in the assessment of risk of bias due to selective 
publication using the SAQAT (κ=0.63, n=29).62 The 
inter-rater agreement of assessments of risk of bias in 
selection of the reported result using the ROBINS-I tool4 
was moderate for NRSI included in a review of the effect 
of cyclooxygenase-2 inhibitors on cardiovascular events 
(κ=0.45, n=21), and substantial for NRSI included in a 
review of the effect of thiazolidinediones on cardiovas-
cular events (κ=0.78, n=16).55
disCussion
From a systematic search of the literature, we identi-
fied 18 tools designed for use by individuals performing 
evidence syntheses to assess risk of reporting biases in the 
included studies or in their synthesis of studies. The tools 
varied with regard to the type of reporting bias assessed 
(eg, bias due to selective publication, bias due to selective 
non-reporting), and the level of assessment (eg, for the 
study as a whole, a particular outcome within a study or a 
particular synthesis of studies). Various criteria are used 
across tools to designate a synthesis as being at ‘high’ 
risk of bias due to selective publication (eg, evidence 
of funnel plot asymmetry, use of non-comprehensive 
searches). However, the relative weight assigned to each 
criterion in the overall judgement is not clear for most of 
these tools. Tools for assessing risk of bias due to selec-
tive non-reporting guide users to assess a study, or an 
outcome within a study, as ‘high’ risk of bias if no results 
are reported for an outcome. However, assessing the 
corresponding risk of bias in a synthesis that is missing 
the non-reported outcomes is outside the scope of most 
of these tools. Inter-rater agreement estimates were avail-
able for five tools,4 21 43 44 62 and ranged from poor to 
substantial; however, the sample sizes of most evaluations 
were small, and few described the weighting scheme used 
to calculate κ.
strengths and limitations
There are several strengths of this research. Methods 
were conducted in accordance with a systematic review 
protocol (https:// osf. io/ 9ea22/). Published articles were 
identified by searching several relevant databases using 
a search string developed in conjunction with an infor-
mation specialist,17 and by contacting experts to identify 
tools missed by the search. Detailed information on the 
content and measurement properties of existing tools 
was collected, providing readers with pertinent informa-
tion to help decide which tools to use in future reviews. 
However, the findings need to be considered in light of 
some limitations. Screening of articles and data collec-
tion were performed by one author only. It is therefore 
possible that some relevant articles were missed, or that 
errors in data collection were made. The search for 
unpublished tools was not comprehensive (only Google 
Scholar was searched), so it is possible that other tools for 
assessing risk of reporting biases exist. Further, restricting 
the search to articles in English was done to expedite the 
review process, but may have resulted in loss of informa-
tion about tools written in other languages, and addi-
tional evidence on measurement properties of tools.
Comparison with other studies
Other systematic reviews of risk of bias tools12–17 have 
restricted inclusion to tools developed for particular 
study designs (eg, randomised trials, diagnostic test accu-
racy studies), where the authors recorded all the sources 
of bias addressed. A different approach was taken in the 
current review, where all tools (regardless of study design) 
that address a particular source of bias were examined. 
By focusing on one source of bias only, the analysis of 
included items and criteria for risk of bias judgements 
was more detailed than that recorded previously. Some 
of the existing reviews of tools15 considered tools that 
were developed or modified in the context of a specific 
systematic review. However, such tools were excluded 
from the current review as they are unlikely to have been 
developed systematically,15 67 and are difficult to find (all 
systematic reviews conducted during a particular period 
would need to have been examined for the search to be 
considered exhaustive).
explanations and implications
Of the 18 tools identified, only four (22%) included a 
mechanism for assessing risk of bias due to selective 
publication, which is the type of reporting bias that has 
been investigated by methodologists most often.2 This is 
perhaps unsurprising given that hundreds of statistical 
methods to ‘detect’ or ‘adjust’ for bias due to selective 
publication have been developed.18 These statistical 
methods may be considered by methodologists and 
systematic reviewers as the tools of choice for assessing 
this type of bias. However, application of these statistical 
methods without considering other factors (eg, existence 
of registered but unpublished studies, conflicts of interest 
that may influence investigators to not disseminate studies 
with unfavourable results) is not sufficiently comprehen-
sive, and could lead to incorrect conclusions about the 
risk of bias due to selective publication. Further, there are 
many limitations of these statistical approaches, in terms 
of their underlying assumptions, statistical power, which 
is often low because most meta-analyses include few 
studies,7 and the need for specialist statistical software to 
apply them.19 68 These factors may have limited their use 
in practice and potentially explain why a large number of 
systematic reviewers currently ignore the risk of bias due 
to selective publication.7–9 69
Our analysis suggests that the factors that need to be 
considered to assess risk of reporting biases adequately 
(eg, comprehensiveness of the search, amount of data 
missing from the synthesis due to unpublished studies 
and under-reported outcomes) are fragmented. A 
similar problem was occurring a decade ago with 
the assessment of risk of bias in randomised trials. 
Some authors assessed only problems with randomis-
ation, while others focused on whether trials were not 
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‘double blinded’ or had any missing participant data.70 
It was not until all the important bias domains were 
brought together into a structured, domain-based tool 
to assess the risk of bias in randomised trials,21 that 
systematic reviewers started to consider risk of bias in 
trials comprehensively. A similar initiative to link all 
the components needed to judge the risk of reporting 
biases into a comprehensive new tool may improve the 
credibility of evidence syntheses.
In particular, there is an emergent need for a new 
tool to assess the risk that a synthesis is affected by 
reporting biases. This tool could guide users to 
consider risk of bias in a synthesis due to both selective 
publication and selective non-reporting, given that 
both practices lead to the same consequence: evidence 
missing from the synthesis.11 Such a tool would comple-
ment recently developed tools for assessing risk of 
bias within studies (RoB 2.041 and ROBINS-I4 which 
include a domain for assessing the risk of bias in selec-
tion of the reported result, but no mechanism to assess 
risk of bias due to selective non-reporting). Careful 
thought would need to be given as to how to weigh up 
various pieces of information underpinning the risk of 
bias judgement. For example, users will need guidance 
on how evidence of known, unpublished studies (as 
identified from trial registries, protocols or regulatory 
documents) should be considered alongside evidence 
that is more speculative (eg, funnel plots suggesting 
that studies may be missing). Further, guidance for the 
tool will need to emphasise the value of seeking docu-
ments other than published journal articles (eg, proto-
cols) to inform risk of bias judgements. Preparation of 
a detailed guidance manual may enhance the usability 
of the tool, minimise misinterpretation and increase 
reliability in assessments. Once developed, evaluations 
of the measurement properties of the tool, such as 
inter-rater agreement and construct validity, should 
be conducted to explore whether modifications to the 
tool are necessary.
ConClusions
There are several limitations of existing tools for assessing 
risk of reporting biases in studies or syntheses of studies, 
in terms of their scope, guidance for reaching risk of bias 
judgements and measurement properties. Development 
and evaluation of a new, comprehensive tool could help 
overcome present limitations.
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